Dana-Farber Cancer Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Dana-Farber Cancer Institute
Mar 22, 2024, 06:12 |
Drugs
Paolo Tarantino: We’re running SATEEN, the first trial of sacituzumab govitecan + trastuzumab in patients with HER2 + MBC
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post by Marta…
Mar 22, 2024, 06:06 |
Blog
Cathy Wu selected for the prestigious Sjöberg Prize for her pioneering research in personalized cancer vaccines - Dana-Farber Cancer Institute
Ron DePinho, Professor of the Department of Cancer Biology, Harry Graves Burkhart III Distinguished University…
Mar 15, 2024, 18:24 |
Drugs
Paolo Tarantino: Final analysis of the PEONY phase 3 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 3, 2024, 06:13 |
Blog
A sneak peek into Narjust Florez's unwavering focus on pregnancy and lung cancer - Florez Lab
Florez Lab shared a post on X/Twitter: ''Just published by Dana-Farber Cancer Institute: 'Guiding Lung…
Feb 29, 2024, 14:42 |
Insight
Researchers at Dana-Farber Cancer Institute and the University of Trento have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma - Dana-Farber Cancer Institute
Feb 22, 2024, 10:58 |
Blog
Toni Choueiri: The 3rd transatlantic exchanges between Dana-Farber Cancer Institute and Gustave Roussy happening on April 12
Toni Choueiri, Senior Executive and Chief of Genitourinary Cancers at Dana-Farber Cancer Institute, shared a…
Feb 19, 2024, 14:16 |
Blog
The inaugural Oncology Symposium at Arab Health was a great success - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute made the following on LinkedIn: "We are pleased to share that the…
Feb 19, 2024, 09:20 |
Insight
Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute
Brandon Huffman, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, shared an…
Feb 19, 2024, 07:17 |
Career
Paolo Tarantino: Honored to be awarded a Terri Brodeur Foundation 2024 Grant
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: "Honored…
Feb 18, 2024, 10:50 |
Blog
Congratulations to Dana-Farber researchers who are among 36 recipients of the ASH 2024 Scholar Awards - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute recently shared a post on LinkedIn: "Congratulations to Dana-Farber researchers Erin Parry,…
Feb 17, 2024, 10:23 |
Blog
Staff from the International Patient Center (IPC) at Dana-Farber share a moment of joy after Laurie H. Glimcher ceremoniously cut a blue ribbon to mark its official opening on Jan. 16 - Dana-Farber Cancer Institute
Feb 8, 2024, 17:54 |
Insight
Paolo Tarantino: Few treatments in oncology allow to achieve more than 50% intracranial response rates, with durable efficacy
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared ESMO Open's post on X/Twitter, adding: "One…
Feb 1, 2024, 15:19 |
Opinion
Paolo Tarantino: Nectin4 amplification predicts response to enfortumab vedotin in metastatic urothelial carcinoma
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared by Niklas…
Jan 31, 2024, 15:28 |
Blog
Jennifer Thalappillil: So excited to be joining the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute as a Scientist focused on scientific writing!
Jennifer Thalappillil, Scientific Writer at Dana-Farber Cancer Institute, shared a post on X/Twitter: "So excited…
Jan 29, 2024, 13:37 |
Blog
Sarah Sammons: Learning about Leptomeningeal Disease in Breast Cancer
Sarah Sammons, Breast Medical Oncologist at Dana-Farber's Breast Oncology Center, shared a post on X/Twitter:…
Jan 28, 2024, 18:44 |
Blog
Interim phase 1 results show HPN328 is well tolerated and clinically active for neuroendocrine carcinomas - Dana-Farber News
Dana-Farber News recently shared a post on their X/Twitter page: "ASCO GU24: Interim phase 1…
Jan 21, 2024, 18:43 |
Blog
Charles Roberts: Pediatric Cancer Dependencies Accelerator has already identified mechanistic, and potentially therapeutic, insights in cancers
Charles Roberts, Executive Vice President at St. Jude’s Research Hospital, shared a post by Association…
Jan 19, 2024, 14:06 |
Insight
Mark Awad: Our group's effort to elucidate mechanisms of resistance to PD-1 immunotherapy in lung cancer
Mark Awad, Director of Clinical Research, Associate Professor of Thoracic Oncology at the Dana-Farber Cancer…
Jan 18, 2024, 15:21 |
Blog
Doug Rubinson: Dana-Farber is creating a Senior VP position in medical education and seeking MD applicants
Doug Rubinson, Assistant Professor at Dana-Farber Cancer Institute, recently shared on LinkedIn: "There is a…
Jan 16, 2024, 17:14 |
Career
Karen Knudsen: Dr. Janne has revolutionized understanding and treatment of lung cancer
Karen Knudsen shared on X: "Magical evening last night in DC as we celebrated the…
Jan 13, 2024, 09:58 |
Blog
Congratulations to Narjust Florez on winning the Dana-Farber Cancer Institute Medical Oncology Team Science Award - Florez Lab
Florez Lab shared a post on their X/Twitter page: "Congratulations to Narjust Florez on winning…
Jan 7, 2024, 15:14 |
Drugs
Paolo Tarantino: Decades of cancer research converging on new effective treatment options for our patients with HR-positive breast cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared on LinkedIn:…
Jan 4, 2024, 16:32 |
Blog
Despite her nerves, she got in - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post LinkedIn: “Chief of the Division of Stem Cell Transplantation…
Dec 30, 2023, 17:51 |
Opinion
Paolo Tarantino: Happy to have worked with Sarah Sammons and Nancy Lin at the ph2 DATO-Base trial
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared a post…
Dec 30, 2023, 17:29 |
Blog
Paolo Tarantino: Ikigai
Paolo Tarantino, Medical Oncologist and Research Fellow at the Dana-Farber Cancer Institute, shared a post…
Dec 24, 2023, 18:54 |
Drugs
Laurie Glimcher: Belzutifan is approved by the FDA
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: "Exciting news that…
Dec 18, 2023, 21:06 |
Insight
Toni Choueiri: A new option for our Kidney Cancer patients!
Toni Choueiri shared on LinkedIn: "JUST IN: FDA approved belzutifan (HIF2 inhibitor) in advanced renal cell…
Dec 13, 2023, 16:21 |
Blog
We are joining forces with Dana-Farber Cancer Institute’s Hale Family Center for Pancreatic Research - Harbinger Health
Harbinger Health shared on their LinkedIn page: ''We are joining forces with Dana-Farber Cancer Institute’s…
Dec 10, 2023, 17:26 |
Career
Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "Congratulations to Mark Awad, MD, PhD who was honored…
Dec 8, 2023, 17:54 |
Career
Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
Dana-Farber News /Dana Farber Cancer Institute/ shared on their X/Twitter account: "Congrats to Dana-Farber Cancer…
Nov 29, 2023, 16:26 |
Blog
Top 10 abstracts to keep an eye on for SABCS 23 by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "10 days to…
Nov 25, 2023, 10:34 |
Blog
Katya Losk: Dana-Farber Cancer Institute was honored to participate in the 3rd Joint Symposium on Academic Development held at the First Affiliated Hospital, Sun Yat-sen University in Guangzhou, China
Nov 24, 2023, 00:35 |
Blog
Congratulations to Zuzana Tothova, MD, PhD who is the recipient of the Doris Duke Foundation's Paragon Award for Research Excellence! - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, made the following post on LinkedIn: "Congratulations to Zuzana Tothova, MD, PhD…
Nov 20, 2023, 04:08 |
Insight
Adam C Palmer: You don’t need ‘1+1 makes 3’ if you can have ‘5+5 makes 10’
David Steensma, Chief Medical Officer at Ajax Therapeutics, and Anthony Letai, Professor at Dana-Farber Cancer…
Nov 8, 2023, 18:09 |
Societies
ASCO has been awarded an $11 million grant from PCORI to support a clinical trial co-led by Erica Mayer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "The American Society of Clinical Oncology (ASCO) has been awarded an $11…
Nov 7, 2023, 18:03 |
Insight
Lachelle Dawn: Excited to share our review article in Blood Journal on the Causes and Consequences of Clonal Hematopoiesis
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on Twitter: "Excited to share…
Nov 6, 2023, 04:03 |
Blog
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "Trastuzumab Deruxtecan (T-DXd)…
Oct 28, 2023, 15:53 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10
Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…
Oct 21, 2023, 21:40 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 9
We continue OncoDaily’s ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
Oct 20, 2023, 20:02 |
Insight
10 ESMO23 breast cancer abstracts not to miss by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on Twitter: "ESMO23 will have…
Oct 20, 2023, 19:58 |
Stories
The work Rosenthal had done to annotate CT scans of patients with pancreatic cancer and more by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "As a cancer imaging fellow at Dana-Farber, Michael Rosenthal,…
Oct 13, 2023, 17:39 |
Blog
Sara Tolaney: Consider applying to the Gilead Research Scholars program if you are a junior faculty member looking for funding for research in solid tumors!
Quoting Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, on…
Oct 12, 2023, 02:36 |
Blog
Paolo Tarantino: Truly grateful for the kind invitation and incredibly warm welcome by the Argentinian and Patagonian associations of clinical oncology.
Quoting Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, on X/Twitter: "Truly…
Oct 7, 2023, 01:14 |
Blog
Fadelu is being honored by HMS for his global work through Dana-Farber's collaboration with the Butaro Cancer Center for Excellence (BCCOE). - Dana-Farber Cancer Institute
Oct 3, 2023, 23:45 |
Insight
Researchers at Dana-Farber Cancer Institute and Boston Medical Center conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution. - Dana-Farber Cancer Institute
Sep 30, 2023, 23:47 |
Blog
Dana-Farber Cancer Institute: Edward P. Evans Center for MDS at Dana-Farber aims create a community of researchers who are committed to advancing translational research in MDS.
Sep 29, 2023, 19:23 |
Blog
The Samuel E. Lux Fellowship is available to Harvard Medical School students who are interested in a full-time year-long research fellowship in a Pediatric Hematology/Oncology laboratory. - Dana-Farber Cancer Institute
Sep 25, 2023, 22:09 |
Blog
Yan Leyfman: Honored to participate in the Legorreta Cancer Center's Symposium on Tumor Plasticity in Diagnosis and Treatment.
Yan Leyfman, Internal Medicine & Clinical Researcher at Icahn School of Medicine at Mount Sinai,…
Sep 24, 2023, 17:52 |
Blog
Vivek Subbiah: Great honor to meet with the amazing and beloved The Nobel Prizewinner Dr. Bill Kaelin Dana-Farber Cancer Institute.
Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn: ''Great…
Sep 23, 2023, 20:01 |
Blog
Wafik S. El-Deiry: Appreciated the historic perspective provided by Dr. Gordon Freeman...
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared on LinkedIn:…
Sep 21, 2023, 04:05 |
Drugs
Paolo Tarantino: The longest follow up to date of a metastatic trastuzumab trial.
Paolo Tarantino, a clinical research fellow at the Dana-Farber Cancer Institute, shared the following insight…
Sep 20, 2023, 18:14 |
Insight
A potential new way to assess clinically valuable features of clear cell renal cell carcinoma (ccRCC)- Dana-Farber News.
Quoting Dana-Farber News on X/Twitter: "Eli Van Allen, Jackson Nyman (Dana-Farber Cancer Institute) and Toni…
Sep 19, 2023, 19:00 |
Stories
The artform is a unique and safe space to explore a topic as weighty as cancer. - Dana-Farber Cancer Institute
Quoting Dana-Farber Cancer Institute on LinkedIn: "At the virtual art event 'Cancer - The Zine…
Sep 16, 2023, 18:50 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 4
Three weeks ago, OncoDaily initiated its series on '100 Influential Women in Oncology: Key Opinion…
Sep 15, 2023, 18:40 |
Blog
Warm welcome and congratulations to CancerX’s inaugural steering committee, which provides an additional layer of governance within our public-private partnership model. - CancerX Moonshot
Sep 11, 2023, 18:26 |
Blog
Paolo Tarantino: Topics like ADCs bring all oncology disciplines closer, reminding us that we’re all together in the fight against cancer.
Quoting Paolo Tarantino, clinical research fellow at the Dana-Farber Cancer Institute, on Twitter: "Proud to…
Sep 3, 2023, 19:39 |
Blog
Toni Choueiri: I’m walking to defy cancer at the Jimmy Fund Walk on October 1.
Toni Choueiri, Senior Executive and Chief GU Cancers at Dana-Farber Cancer Institute and Professor of…
Aug 29, 2023, 18:43 |
Blog
Paolo Tarantino: So many changes since last year... one thing, though - one corner, remained the same. Luckily.
Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on X/Twitter: "So many changes…
Aug 23, 2023, 15:03 |
Blog
Past and present leaders from Dana-Farber shared their perspectives on their careers. - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute's X/Twitter page recently shared: "We’ve just released a series of videos from…
Aug 10, 2023, 19:01 |
Career
At a recent meeting of Dana-Farber Cancer Institute Board of Trustees, two new trustees were elected to serve three-year terms - Dana-Farber Cancer lnstitute
At a recent meeting of Dana-Farber Cancer Institute Board of Trustees, two new trustees were…
Aug 9, 2023, 19:09 |
Career
To all pathology fellows/residents interested in a research post-doc - Toni Choueiri
To all pathology fellows/residents interested in a research post-doc focused on prostate cancer ==> we…
Jul 12, 2023, 05:51 |
Blog
More than 220 community leaders attended the Women's Leadership Breakfast hosted by the Executive Council of the Susan F. Smith Center for Women's Cancers - Dana-Farber Cancer Institute
May 26, 2023, 15:07 |
Stories
“It was truly a whirlwind going from radiation that morning, but so, so worth it,” - Maggie Gove
Last Friday morning, Maggie Gove, 14, had radiation treatment for cancer. That night she had…
1
2
3
All:
263
Posts:
201 - 300
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube